Video

Video Highlights From the 2012 ONS Congress

Author(s):

The Oncology Nursing Society (ONS) 37th Annual Congress video highlights, from OncLive TV.

Carol Bush on the MCA Telehealth Network

Carol J. Bush, BS, RN, Patient Navigator, Midwest Cancer Alliance, The University of Kansas Cancer Center, discusses the telehealth network used by the Midwest Cancer Alliance (MCA) to provide access to the ONS Chemotherapy and Biotherapy training for oncology nurses in rural areas.

Krista Rubin on Managing Ipilimumab-related Dermatitis

Krista Rubin, MS, RN, FNP-BC, Center for Melanoma, Massachusetts General Hospital Cancer Center, discusses the management of immune-mediated dermatitis, a common side effect of ipilimumab (Yervoy), an immunotherapy used to treat patients with advanced melanoma.

Erin McMenamin on HPV-related Head & Neck Cancer

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses the prognosis for patients with human papillomavirus (HPV)-positive squamous cell carcinoma of the head and neck.

Anna Vioral on Multidisciplinary Chemotherapy Safety Standards

Anna Vioral, MSN, MEd, RN, OCN®, Oncology, West Penn Allegheny Health System, summarizes a three year effort to standardize and integrate a set of multidisciplinary chemotherapy safety standards, which used the preexisting recommendations from the American Society of Clinical Oncology (ASCO) and Oncology Nursing Society (ONS).

Michael Eckenfels on Bortezomib Delivery Route Changes

Michael Eckenfels, BSN, LMSW, RN, OCN®, Lymphoma Myeloma Center, MD Anderson Cancer Center, discusses a nurse-led project that sought to reduce the incidence of bortezomib (Velcade)-related peripheral neuropathy in patients with multiple myeloma.

Mary Gullatte Discusses Nursing Shortages

Mary Gullatte, PhD, RN, APRN, BC, AOCN®, FAAN, associate chief nursing officer, Emory University Hospital Midtown, president, Oncology Nursing Society, discusses the factors that contribute to nursing shortages and what may be behind an apparent lack of shortages.

Anne Katz Discusses Cancer and Sexuality

Anne Katz, RN, PhD, editor, Oncology Nursing Forum, Manitoba Prostate Centre, University of Manitoba, CancerCare Manitoba, discusses the impact of cancer on sexual functioning and health, which can be connected to the tumor itself, effects of the treatment, emotions, or changes in a patient’s self image.

Jayshree Shah on the Safety and Efficacy of Nilotinib

Jayshree Shah, RN, APN-C, MSN, BSN, BS, Nurse Practitioner, Leukemia Division, John Theurer Cancer Center, Hackensack University Medical Center, discusses the safety and efficacy of nilotinib (Tasigna), a selective BCR-ABL kinase inhibitor for patients with chronic myeloid leukemia (CML).

Kim Kelly on Clinical Practice Guidelines for Mucositis

Kim Kelly, RN, OCN, Oncology, John Theurer Cancer Center, Hackensack University Medical Center, discusses the analysis that led to the new MASCC/ISOO clinical practice guidelines for managing mucositis, presented in an abstract at the 2012 ONS Annual Congress.

Over 3000 nurses gathered in New Orleans for the Oncology Nursing Society (ONS) 37th Annual Congress. Here are some of the video highlights from the conference, from OncLive TV:

<<<

View more from the 2012 ONS Congress

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center